{
  "ptid_time": "057_S_0839_2007-10-03",
  "img_path": "/data/qiuhui/data/adni/images/057_S_0839/2007-10-03/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 30,695 mm³, 17.0% below the reference mean. With a Z-score of -0.46 (32.4th percentile), this represents normal volume ; hippocampal volume measures 5,205 mm³, 19.9% below the reference mean. With a Z-score of -1.59 (5.6th percentile), this represents moderate atrophy; whole brain volume measures 783,529 mm³, 15.6% below the reference mean. With a Z-score of -1.87 (3.1th percentile), this represents moderate atrophy; entorhinal cortex volume measures 2,633 mm³, 24.0% below the reference mean. With a Z-score of -1.29 (9.8th percentile), this represents mild atrophy; fusiform gyrus volume measures 13,361 mm³, 17.1% below the reference mean. With a Z-score of -1.28 (10.0th percentile), this represents mild atrophy; middle temporal gyrus volume measures 13,344 mm³, 26.0% below the reference mean. With a Z-score of -2.31 (1.0th percentile), this represents significant atrophy. ",
  "text_data": "Age is 80.4 years. Gender is Female. Education: 9 years. MMSE: 27.0. Logical Memory: 2.0. APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 668.70 pg/mL (normal ); Total tau: 458.30 pg/mL (significant elevated); Phosphorylated tau: 45.12 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the middle temporal gyrus (Z-score -2.31, 1.0th percentile) and moderate atrophy in the hippocampus (Z-score -1.59, 5.6th percentile) and whole brain (Z-score -1.87, 3.1th percentile), which are key regions affected in Alzheimer's disease. The CSF biomarkers (normal Aβ but elevated T-tau and P-tau) suggest neurodegeneration consistent with AD pathology, despite the relatively preserved MMSE score (27/30).  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease**  \n**Confidence:** **High**  \n\n*(Note: The MMSE is near-normal, but the structural and biomarker findings strongly suggest early AD pathology. The absence of significant functional decline would place this in the MCI stage rather than dementia.)*",
  "timestamp": "2025-07-26T08:05:44.344294"
}